Lacosamide Validated as Promising Therapy for Uncontrolled Partial-Onset Seizures, Barrow Neurological Institute, St. Joseph’s Hospital, And Thomas Jefferson University Study

ScienceDaily (Mar. 9, 2010) — A recent multi-center study has confirmed earlier study results that 400 mg/day of lacosamide provides a good balance of efficacy and tolerability for patients with uncontrolled partial-onset seizures (POS), and doses of 600mg/day may provide additional benefit for some patients.